Literature DB >> 6322309

Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells.

E Gönczöl, P W Andrews, S A Plotkin.   

Abstract

To study the mode of action of human cytomegalovirus, an important teratogenic agent in human populations, the susceptibility of a pluripotent human embryonal carcinoma cell line to the virus was investigated. Viral antigens were not expressed nor was infectious virus produced by human embryonal carcinoma cells after infection, although the virus was able to penetrate these cells. In contrast, retinoic acid-induced differentiated derivatives of embryonal carcinoma cells were permissive for antigen expression and infectious virus production. Replication of human cytomegalovirus in human teratocarcinoma cells may therefore depend on cellular functions associated with differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322309     DOI: 10.1126/science.6322309

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  74 in total

Review 1.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

2.  Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor.

Authors:  S L Shelbourn; S K Kothari; J G Sissons; J H Sinclair
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.

Authors:  Xiaoqiu Liu; Jinxiang Yuan; Allen W Wu; Patrick W McGonagill; Courtney S Galle; Jeffery L Meier
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.

Authors:  J A Nelson; C Reynolds-Kohler; B A Smith
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

5.  Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Authors:  Ryan T Saffert; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

Review 6.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

7.  Repression by a differentiation-specific factor of the human cytomegalovirus enhancer.

Authors:  T H Huang; T Oka; T Asai; T Okada; B W Merrills; P N Gertson; R H Whitson; K Itakura
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 8.  Recent progress in cytomegalovirus research.

Authors:  J D Benson; E S Huang
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

Review 9.  Antiviral resistance of stem cells.

Authors:  Xianfang Wu; Andrew C Kwong; Charles M Rice
Journal:  Curr Opin Immunol       Date:  2018-10-20       Impact factor: 7.486

10.  Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.

Authors:  N Y Harel; J C Alwine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.